
Publication
Controlled Goods Data: Overview of the Regulatory Framework
The Controlled Goods Program (“CGP”) is Canada’s domestic industrial security program, which regulates the examination, possession, and transfer of controlled goods.
United States | Publication | March 9, 2022
As reported in prior alerts, US OSHA enforces whistleblower provisions in 25 federal statutory schemes protecting employees from retaliation for reporting workplace health and safety problems. These statutes address protected employee activities across virtually every industry segment and are addressed in OSHA’s Whistleblower Protection Program.
On March 8, 2022, OSHA published an interim final rule concerning employee retaliation complaints under the Taxpayer First Act (TFA). Enacted on July 1, 2019, TFA protects employees who report underpayment of taxes or other potential federal tax law violations.
Since this is an interim rule, OSHA is soliciting public comments by May 6, 2022 (submit comments online, identified by Docket No. OSHA–2020–0006) via the Federal eRulemaking Portal. Additional details about the statute and instructions on filing a TFA complaint with OSHA are outlined in Whistleblower Protection for Employees Who Report Federal Tax Law Violations.
Publication
The Controlled Goods Program (“CGP”) is Canada’s domestic industrial security program, which regulates the examination, possession, and transfer of controlled goods.
Publication
On August 25, 2025, the Government of Alberta publicly re-affirmed its interest in nuclear energy with the launch of its Nuclear Energy Engagement (the Engagement).
Publication
Health Canada has proposed a major change to the regulation of biosimilar drugs that may accelerate biologic patent litigation in Canada. Following the lead of other jurisdictions, Health Canada has proposed that biosimilar manufacturers no longer be required to conduct phase 3 clinical trials to enter the Canadian market.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025